TRANSMUKOSALES PFLASTER MIT EINEM CANNABINOID UND/ODER EINEM OPIOID

European patent · EP4124336 · In force

Register entry

Publication number
EP4124336
Application number
EP21188925
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 30, 2021
Published
Feb 1, 2023
Granted
Oct 25, 2023
Protection ends at the latest
Jul 29, 2041
Next annual fee due
Jul 31, 2026
IPC classes
A61K 9/70 (2006.01)
A61K 31/352 (2006.01)
A61K 31/05 (2006.01)
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2025

    Change

    Published in Swissreg on 01.08.2025

  2. Sep 4, 2024

    Change

    Published in Swissreg on 04.09.2024

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Oct 25, 2023

    Granted

    Published in Swissreg on 25.10.2023

Parties

Holder

Cannamedical Pharma GmbH

Im Mediapark 8, 50670 Köln, DE

Inventor

VON COBURG, Yvonne

53773 Hennef, DE

WALTHER, Marcel

60433 Frankfurt am Main, DE

PLANZ, Viktoria

60439 Frankfurt am Main, DE

FREY, Nadine

51067 Köln, DE

WALTHER, Alice

60320 Frankfurt am Main, DE

SEIFERT, Anke

52074 Aachen, DE

WINDBERGS, Maike

61462 Königstein im Taunus, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.